DAFNA Capital Management LLC
Q1 2025 13F Holdings
- Locationlos angeles, CA
- Num holdings
83
- Value ($000)
$352,662
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001389933
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
KRE SPDR S&P BIOTECH ETF | ETF | 78464A870 | $32.81M | 9 % | 404,505 | ||
RJR1 STEREOTAXIS INC | COM NEW | 85916J409 | $24.08M | 7 % | 13,680,554 | ||
RVMD REVOLUTION MEDICINES INC | COM | 76155X100 | $23.20M | 7 % | 656,176 | ||
MERUS N V | COM | N5749R100 | $19.44M | 6 % | 461,804 | ||
ATRC ATRICURE INC | COM | 04963C209 | $19.11M | 5 % | 592,273 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $16.00M | 5 % | 398,100 | ||
BPMC BLUEPRINT MEDICINES CORP | COM | 09627Y109 | $13.48M | 4 % | 152,263 | ||
IBB ISHARES NASDAQ BIOTECH INDX | ETF | 464287556 | $13.11M | 4 % | 102,500 | ||
AXGN AXOGEN INC | COM | 05463X106 | $12.59M | 4 % | 680,782 | ||
ASND ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | $12.53M | 4 % | 80,398 |
Rows Per Page
10
- 10
- 50
- 100